Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
520 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT02559154 | Modified Bortezomib-based Combination Therapy for Multiple Myeloma | unknown | Phase 4 | 80 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 4, 2018 |
| NCT03513601 | Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma | unknown | Phase 4 | 20 | Mingzhi ZhangOTHER | 1 | May 1, 2018 | clinicaltrials |
| NCT03500367 | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | unknown | Phase 4 | 25 | Peking Union Medical College HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02034799 | Phase IV Bioseal Study in Brain Tumor Surgery | completed | Phase 4 | 256 | Ethicon, Inc.INDUSTRY | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03178656 | A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis | unknown | Phase 4 | 54 | Huazhong University of Science and TechnologyOTHER | 1 | Dec 21, 2017 | clinicaltrials |
| NCT02299765 | Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC | terminated | Phase 4 | 61 | Sichuan UniversityOTHER | 1 | Nov 27, 2017 | clinicaltrials |
| NCT01746992 | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma | unknown | Phase 4 | 200 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT01770431 | Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy | completed | Phase 4 | 1,044 | Qidong Gaitianli Medicines Co., LtdINDUSTRY | 1 | Oct 2, 2017 | clinicaltrials |
| NCT02765594 | Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy(HCQIgAN) | unknown | Phase 4 | 98 | Peking Union Medical College HospitalOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT03253250 | The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection | unknown | Phase 4 | 432 | Huashan HospitalOTHER | 1 | Sep 8, 2017 | clinicaltrials |
| NCT03206684 | To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer | unknown | Phase 4 | 20 | Air Force Military Medical University, ChinaOTHER | 1 | Aug 28, 2017 | clinicaltrials |
| NCT02404675 | High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation(INCREASE) | unknown | Phase 4 | 240 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02346318 | The Randomized Controlled Clinical Trial of Kushen Injection | unknown | Phase 4 | 240 | Beijing Zheng Ju Medical Technology Co., Ltd.INDUSTRY | 1 | Jul 21, 2017 | clinicaltrials |
| NCT03180970 | Different Lugol's Solution Concentration for Image Quality of Esophageal Lesions in Chromoendoscopy With Iodine Staining | unknown | Phase 4 | 50 | Shandong UniversityOTHER | 1 | Jun 8, 2017 | clinicaltrials |
| NCT03150134 | Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients | unknown | Phase 4 | 100 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 12, 2017 | clinicaltrials |
| NCT03127072 | Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM | unknown | Phase 4 | 200 | Fudan UniversityOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02651519 | Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation | completed | Phase 4 | 105 | China Medical University, ChinaOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT01959061 | Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases(TACE) | unknown | Phase 4 | 320 | Nanjing Chia-tai Tianqing PharmaceuticalINDUSTRY | 1 | Mar 13, 2017 | clinicaltrials |
| NCT02088515 | Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma | completed | Phase 4 | 290 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03069820 | Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury | unknown | Phase 4 | 120 | Second Affiliated Hospital of Nanchang UniversityOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT02553187 | A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia | unknown | Phase 4 | 160 | Zhejiang Kanglaite Pharmaceutical Co.LtdOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT01665417 | Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | unknown | Phase 4 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03026842 | Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21) | unknown | Phase 4 | 180 | The First Hospital of Jilin UniversityOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT03017053 | The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor | unknown | Phase 4 | 270 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT01765231 | Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma | unknown | Phase 4 | 190 | Peking UniversityOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT01768195 | Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy | unknown | Phase 4 | 80 | Peking UniversityOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT03010579 | Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation | unknown | Phase 4 | 70 | Peking UniversityOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT02487316 | A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib | withdrawn | Phase 4 | 0 | Jun ZhuOTHER | 1 | Dec 30, 2016 | clinicaltrials |
| NCT01301729 | A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment | completed | Phase 4 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Dec 29, 2016 | clinicaltrials |
| NCT02999308 | A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children(CHIPS) | unknown | Phase 4 | 40 | Beijing Children's HospitalOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT02996617 | PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia | unknown | Phase 4 | 240 | Shandong Provincial HospitalOTHER_GOV | 1 | Dec 19, 2016 | clinicaltrials |
| NCT02992834 | Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma | unknown | Phase 4 | 10 | jiangjingtingOTHER | 1 | Dec 14, 2016 | clinicaltrials |
| NCT02348450 | Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer | unknown | Phase 4 | 308 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02982148 | Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients | unknown | Phase 4 | 352 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02089854 | Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer(AETNBC) | unknown | Phase 4 | 800 | Peking Union Medical College HospitalOTHER | 1 | Dec 2, 2016 | clinicaltrials |
| NCT02953730 | The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents | completed | Phase 4 | 9 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT01669369 | Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma(Li2CO3) | unknown | Phase 4 | 400 | Sun Yat-sen UniversityOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT02945267 | Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | unknown | Phase 4 | 60 | Chinese PLA General HospitalOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT02938741 | ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors | unknown | Phase 4 | 130 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT02929615 | Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors | unknown | Phase 4 | 50 | Peking UniversityOTHER | 1 | Oct 12, 2016 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT01664975 | Treatment of Peripheral T-cell Lymphoma | completed | Phase 4 | 100 | Mingzhi ZhangOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT02027064 | Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT | unknown | Phase 4 | 40 | Peking University People's HospitalOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02810899 | Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy | completed | Phase 4 | 60 | Peking University First HospitalOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02905916 | The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy | unknown | Phase 4 | 217 | Peking UniversityOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02905942 | PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation | unknown | Phase 4 | 96 | Peking UniversityOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02903524 | Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer | unknown | Phase 4 | 300 | Hebei Medical University Fourth HospitalOTHER | 1 | Sep 16, 2016 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials